Signalb7c6da73

WEBINDEXED

PhRMA spent $28M lobbying Congress in 2022, correlating with defeat of drug price negotiation amendments in Inflation Reduction Act markup.

Published:2023-01-15 00:00 UTC

Occurred:2022-12-01 00:00 UTC

Received:2026-07-15 08:00 UTC

Status Score

80%

ITG

85%

IMP

75%

NAR

30%

Analysis Insights

Topics Detected

#Lobbying Spend#Drug Pricing

Entities Mentioned

@PhRMA@Congress@Inflation Reduction Act

Technical Details

Analyst Mission

Corporate Lobbying Trackera76754d3...

Source IDN/A

Original URLN/A

Database IDb7c6da73-846b-4038-9530-b19315ceac91

Raw Data

{
  "id": "b7c6da73-846b-4038-9530-b19315ceac91",
  "content": "PhRMA spent $28M lobbying Congress in 2022, correlating with defeat of drug price negotiation amendments in Inflation Reduction Act markup.",
  "url": null,
  "source_type": "web",
  "source_id": null,
  "author_id": null,
  "published_at": "2023-01-15T00:00:00.000Z",
  "received_at": "2026-07-15T08:00:25.708Z",
  "status": "indexed",
  "relevance_score": 80,
  "case_id": null,
  "metadata": {
    "topics": [
      "Lobbying Spend",
      "Drug Pricing"
    ],
    "mission": "Corporate Lobbying Tracker",
    "mentions": [
      "PhRMA",
      "Congress",
      "Inflation Reduction Act"
    ],
    "mission_id": "a76754d3-444f-44d8-bf31-a548a575182e"
  },
  "credibility_score": 85,
  "actionability_score": 75,
  "emotional_score": 30,
  "occurred_at": "2022-12-01T00:00:00.000Z",
  "case_ids": null
}